Mary Tolikas, PhD, MBA, joined Dana-Farber in 2022 to lead the Belfer Office for Dana Farber Innovations. She also manages Binney Street Capital, DFCI’s venture fund, and serves as a member of advisory boards and committees for numerous organizations, including BIH Center for Regenerative Therapies in Berlin, Institut Curie in Paris, and MIT HEALS.
Dr. Tolikas has more than two decades of experience in establishing and growing technology-based organizations in both industry and academia. Prior to joining Dana-Farber, she was CEO of the Wyss Center for Bio and Neuroengineering in Geneva, Switzerland, where she led the Center’s activities in the development and commercialization of a wide range of neurotechnologies.
Dr. Tolikas also played a central role in the launch and growth of the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she spent nearly 10 years on the leadership team as the Institute’s Operations Director. At Harvard, she also served as Executive Director for Special Projects in the Office of the Provost, and was co-instructor in the Master in Design Engineering Program, offered by the Harvard School of Engineering & Applied Science and the Harvard Graduate School of Design.
Dr. Tolikas holds a BEng degree in Electrical and Electronics Engineering from the University of Glasgow, Scotland, MSc and PhD degrees in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology (MIT), and an MBA from the Sloan School of Management at MIT.